{
  "id": 6831783,
  "title": "BillionToOne SVP John ten Bosch sells $138,116 in shares",
  "url": "https://urgent.news/2026/09/12/billiontoone-svp-john-ten-bosch-sells-138-116-in-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-12T00:45:59.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/billiontoone-svp-john-ten-bosch-sells-138116-in-shares-93CH-4898580"
  },
  "original_language": "en",
  "account": "John Roderick ten Bosch, Senior Vice President of Laboratory Operations at BillionToOne, Inc., sold 1,416 shares of the company's Class A Common Stock for $138,116 on September 9, 2026. This transaction, executed under a Rule 10b5-1 trading plan adopted on June 2, 2026, left Mr. ten Bosch with a remaining holding of 25,051 shares. As of the sale, BillionToOne's stock was trading near $98.77, resulting in a market capitalization of $4.65 billion. Despite the sale, the company continues to exhibit high growth potential, with a P/E ratio of 128 and a 54% return over the past six months. However, the stock recently faced a decline after BillionToOne reported strong Q2 earnings, surpassing expectations with an EPS of $0.15 and revenue increasing by 64% to $109.4 million. Canaccord Genuity initiated coverage, giving the company a buy rating and a price target of $120.00, citing BillionToOne's proprietary technologies as key differentiators.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}